Prosecution Insights
Prosecution Insights
Tech Center 2100 • Art Units: 1632 1671 1682 1687 2143
This examiner grants 38% of resolved cases
Joseph Constantine Pulliam is an examiner in Tech Center 2100 and Art Unit 1632. He has handled 63 resolved cases with an allowance rate of 38.1 percent. This 38.1 percent rate indicates a challenging environment where fewer than half of the applications reach a grant.
The interview lift is 31.2 percent. This figure suggests that conducting an interview is a highly effective strategy for increasing the likelihood of a grant. The 31.2 percent lift provides a substantial boost to the allowance rate, making it a critical tactic for practitioners to consider.
The median days to allowance is 1816. This timeline represents the typical duration for applications to reach a final grant. With 63 resolved cases, these metrics offer a clear view of the examiner's performance. The 1816-day median defines the expected prosecution experience for applicants in this docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17477849 | METHOD AND APPARATUS FOR ANALYSIS OF HISTOPATHOLOGY DATASETS | Non-Final OA | Siemens Healthcare GmbH |
| 17187298 | METHODS FOR PROFILING AND QUANTITATING CELL-FREE RNA | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17927824 | A MODELING METHOD FOR ARTIFICIAL NEURAL PATHWAY ACROSS ENCEPHALIC REGIONS | Non-Final OA | ZHEJIANG UNIVERSITY |
| 17291723 | METHODS TO PREDICT LIVER DISEASE MORTALITY USING LIPOPROTEIN LP-Z | Non-Final OA | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. |
| 17883619 | MACHINE LEARING BASED METHOD OF SCREENING POTENTIAL DRUG CANDIDATE, AND A METHOD THEREOF | Non-Final OA | City University of Hong Kong |
| 16429997 | METHODS AND SYSTEMS FOR DETERMINING The CELLULAR ORIGIN OF CELL-FREE NUCLEIC ACIDS | Non-Final OA | GUARDANT HEALTH, INC. |
| 18011687 | METHODS AND COMPOSITIONS FOR THE MOLECULAR DIAGNOSIS OF MICROSATELLITE INSTABILITY AND TREATMENTS FOR CANCER | Final Rejection | UNIVERSITY OF WASHINGTON |
| 18236812 | Calibration Method, Apparatus and Computer Program Product | Non-Final OA | Gen-Probe Incorporated |
| 17111272 | COPY NUMBER VARIANT CALLER | Non-Final OA | MYRIAD WOMEN'S HEALTH, INC. |
| 18322140 | COMPOSITION SWEETNESS, BITTERNESS, UMAMI, LICORICE, LINGERING, SOURNESS OR SALTINESS PERCEPTION PREDICTION METHOD AND SYSTEM | Non-Final OA | Firmenich SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy